STSA Annual EBITDA
-$69.36 M
-$18.74 M-37.03%
31 December 2022
Summary:
As of February 5, 2025, STSA annual earnings before interest, taxes, depreciation & amortization is -$69.36 million, with the most recent change of -$18.74 million (-37.03%) on December 31, 2022. During the last 3 years, it has fallen by -$41.81 million (-151.74%).STSA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA Quarterly EBITDA
-$10.26 M
+$12.65 M+55.23%
31 March 2023
Summary:
As of February 5, 2025, STSA quarterly earnings before interest, taxes, depreciation & amortization is -$10.26 million, with the most recent change of +$12.65 million (+55.23%) on March 31, 2023. Over the past year, it has increased by +$5.12 million (+33.30%).STSA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA TTM EBITDA
-$64.24 M
+$5.12 M+7.38%
31 March 2023
Summary:
As of February 5, 2025, STSA TTM earnings before interest, taxes, depreciation & amortization is -$64.24 million, with the most recent change of +$5.12 million (+7.38%) on March 31, 2023. Over the past year, it has dropped by -$8.57 million (-15.39%).STSA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STSA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.0% | +33.3% | -15.4% |
| 3 y3 years | -151.7% | +12.0% | -75.8% |
| 5 y5 years | -1247.6% | -552.5% | -133.2% |
STSA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1247.6% | +552.5% | +3986.5% |
Satsuma Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$10.26 M(-55.2%) | -$64.24 M(-7.4%) |
| Dec 2022 | -$69.36 M(+37.0%) | -$22.91 M(+53.2%) | -$69.36 M(+12.1%) |
| Sept 2022 | - | -$14.95 M(-7.3%) | -$61.88 M(+2.9%) |
| June 2022 | - | -$16.12 M(+4.9%) | -$60.12 M(+8.0%) |
| Mar 2022 | - | -$15.38 M(-0.3%) | -$55.67 M(+10.0%) |
| Dec 2021 | -$50.62 M(+7.8%) | -$15.43 M(+17.0%) | -$50.62 M(+6.3%) |
| Sept 2021 | - | -$13.19 M(+12.9%) | -$47.59 M(+2.5%) |
| June 2021 | - | -$11.68 M(+13.2%) | -$46.45 M(+1.2%) |
| Mar 2021 | - | -$10.32 M(-16.8%) | -$45.89 M(-2.8%) |
| Dec 2020 | -$46.97 M | -$12.40 M(+3.0%) | -$47.22 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$12.05 M(+8.4%) | -$45.47 M(+9.5%) |
| June 2020 | - | -$11.12 M(-4.6%) | -$41.52 M(+13.6%) |
| Mar 2020 | - | -$11.65 M(+9.4%) | -$36.54 M(+32.6%) |
| Dec 2019 | -$27.55 M(+282.7%) | -$10.65 M(+31.5%) | -$27.55 M(+44.0%) |
| Sept 2019 | - | -$8.10 M(+32.0%) | -$19.13 M(+51.8%) |
| June 2019 | - | -$6.14 M(+130.5%) | -$12.60 M(+94.9%) |
| Mar 2019 | - | -$2.66 M(+19.4%) | -$6.46 M(+70.0%) |
| Dec 2018 | -$7.20 M(+39.9%) | -$2.23 M(+41.9%) | -$3.80 M(+141.9%) |
| Sept 2018 | - | -$1.57 M | -$1.57 M |
| Dec 2017 | -$5.15 M | - | - |
FAQ
- What is Satsuma Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals annual EBITDA year-on-year change?
- What is Satsuma Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Satsuma Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Satsuma Pharmaceuticals?
- What is Satsuma Pharmaceuticals TTM EBITDA year-on-year change?
What is Satsuma Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of STSA is -$69.36 M
What is the all time high annual EBITDA for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$5.15 M
What is Satsuma Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, STSA annual earnings before interest, taxes, depreciation & amortization has changed by -$18.74 M (-37.03%)
What is Satsuma Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of STSA is -$10.26 M
What is the all time high quarterly EBITDA for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.57 M
What is Satsuma Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, STSA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$5.12 M (+33.30%)
What is Satsuma Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of STSA is -$64.24 M
What is the all time high TTM EBITDA for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.57 M
What is Satsuma Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, STSA TTM earnings before interest, taxes, depreciation & amortization has changed by -$8.57 M (-15.39%)